EP4237411
AVACOPAN AND RELATED COMPOUNDS OF FORMULA (I) FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA IN PATIENTS HAVING A HURLEY SCORE OF STAGE III
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
27.10.2021EP published:
6.5.2026EP application number:
21887450.1
EPO information:
European Patent Register
Max expiry date:
26.10.2041Expiry date:
26.10.2026
Title in English:
AVACOPAN AND RELATED COMPOUNDS OF FORMULA (I) FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA IN PATIENTS HAVING A HURLEY SCORE OF STAGE IIILanguage of the patent:
English
Timeline
Today
27.10.2021EP application
6.5.2026EP Publication
26.10.2026Expires
Owner
Name:
ChemoCentryx, Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320, US
Inventor
Name:
LI, ShijieAddress:
Los Altos, California 94022, US
Name:
SINGH, RajinderAddress:
Belmont, California 94002, US
Name:
SCHALL, Thomas J.Address:
Thousand Oaks, California 91320, US
Name:
STAEHR, PeterAddress:
Thousand Oaks, California 91320, US
Priority
Number:
202063106557 PDate:
28.10.2020Country:
US
Number:
202063106858 PDate:
28.10.2020Country:
US
Classification
Categories:
A61K 31/451, C07D 215/54, C07D 405/12, A61P 17/00, A61P 29/00, A61P 37/00